Wren Laboratories, located in Branford, CT, is a CLIA-certified diagnostics laboratory specializing in molecular cancer diagnostics. Their non-invasive liquid biopsy oncology tests provide real-time and actionable disease diagnostics using blood or saliva samples. With a suite of proprietary bioanalytics and bioinformatic algorithms, Wren Laboratories analyzes molecular biomarkers for various types of cancer, including neuroendocrine tumors and prostate cancer, equipping oncologists with critical information for accurate diagnosis and treatment decisions.
Utilizing quantitative polymerase chain reaction (qPCR) methodology, Wren Laboratories detects and analyzes cancer-associated mRNA transcripts, providing enhanced efficiency and high accuracy in characterizing tumors. Their MultiAnalyte Algorithm Analytic (MAAA) approach increases the sensitivity and specificity of gene assays, resulting in improved tumor characterization. With a mission to enhance pathology and imaging, Wren Laboratories aims to clarify cancer diagnoses, enabling oncologists to recommend, manage, and monitor treatment more effectively.
Generated from the website